| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Cardiovascular-Pulmonary Research Laboratory, Departments of 1 Medicine and 2 Physiology, University of Colorado Health Sciences Center, Denver, Colorado 80262
Rats with liver cirrhosis exhibit the hepatopulmonary syndrome composed of blunted hypoxic pulmonary vasoconstriction and arterial hypoxemia. The purpose of this study was to investigate the roles of nitric oxide (NO) and endothelin-1 (ET-1) in the blunted hypoxic pressor response (HPR) in rats with common bile duct ligation (CBDL). Lungs from CBDL rats exhibited markedly blunted HPR, increased endothelial NO synthase (NOS) protein expression, and decreased ET-1 mRNA and peptide expression. The blunted HPR was not reversed by sequential NOS and soluble guanylyl cyclase inhibition by nitro-L-arginine and 1H-[1,2,4]oxadiazolo[4,3-a]quinoxaline-1-one (ODQ), respectively, or by NOS inhibition combined with ET-1 addition. The blunted HPR was not due to a generalized inability to vasoconstrict because perfusion pressure was equally elevated by increased perfusate KCl in CBDL and sham lungs. After KCl vasoconstriction, HPR was potentiated and did not differ between CBDL and sham lungs. Blunted HPR was also completely restored in CBDL lungs treated with nitro-L-arginine, ODQ, and the Ca2+-activated K+ channel blockers apamin and charybdotoxin. These results indicate that although CBDL-induced liver cirrhosis is associated with increased NO and decreased ET-1 in the lung, the blunted HPR is a result of additional factors and appears to involve Ca2+-activated K+ channel activation.
pulmonary circulation; liver cirrhosis; nitric oxide; calcium-activated potassium channel; endothelin-1
This article has been cited by other articles:
|
|
 |
|
  R. Rodriguez-Roisin and M. J. Krowka Hepatopulmonary Syndrome -- A Liver-Induced Lung Vascular Disorder N. Engl. J. Med., May 29, 2008; 358(22): 2378 - 2387. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Imamura, Y. Waseda, G. V. Marinova, T. Ishibashi, S. Obayashi, A. Sasaki, A. Nagai, and H. Azuma Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2081 - R2089. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Frossard, E. Schiffer, B. Cikirikcioglu, J. Bourquin, D. R. Morel, and C. M. Pastor Opposite regulation of endothelial NO synthase by HSP90 and caveolin in liver and lungs of rats with hepatopulmonary syndrome Am J Physiol Gastrointest Liver Physiol, October 1, 2007; 293(4): G864 - G870. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Imamura, B. Luo, J. Limbird, A. Vitello, M. Oka, D. D. Ivy, I. F. McMurtry, C. V. Garat, M. B. Fallon, and E. P. Carter Hypoxic pulmonary hypertension is prevented in rats with common bile duct ligation J Appl Physiol, February 1, 2005; 98(2): 739 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Liu, O. V. Evgenov, and F. Ichinose NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice J Appl Physiol, February 1, 2005; 98(2): 748 - 752. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ikai, M. Shirai, K. Nishimura, T. Ikeda, T. Kameyama, K. Ueyama, and M. Komeda Hypoxic pulmonary vasoconstriction disappears in a rabbit model of cavopulmonary shunt J. Thorac. Cardiovasc. Surg., May 1, 2004; 127(5): 1450 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Morio, E. P. Carter, M. Oka, and I. F. McMurtry EDHF-mediated vasodilation involves different mechanisms in normotensive and hypertensive rat lungs Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1762 - H1770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Littler, K. G. Morris Jr., K. A. Fagan, I. F. McMurtry, R. O. Messing, and E. C. Dempsey Protein kinase C-epsilon -null mice have decreased hypoxic pulmonary vasoconstriction Am J Physiol Heart Circ Physiol, April 1, 2003; 284(4): H1321 - H1331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Budhiraja and P. M. Hassoun Portopulmonary Hypertension: A Tale of Two Circulations Chest, February 1, 2003; 123(2): 562 - 576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Miyazono, C. Garat, K. G. Morris Jr., and E. P. Carter Decreased renal heme oxygenase-1 expression contributes to decreased renal function during cirrhosis Am J Physiol Renal Physiol, November 1, 2002; 283(5): F1123 - F1131. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Carter, C. L. Hartsfield, M. Miyazono, M. Jakkula, K. G. Morris Jr., and I. F. McMurtry Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome Am J Physiol Lung Cell Mol Physiol, August 1, 2002; 283(2): L346 - L353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. NUNES, D. LEBREC, M. MAZMANIAN, F. CAPRON, J. HELLER, K. A. TAZI, E. ZERBIB, E. DULMET, R. MOREAU, A. T. DINH-XUAN, et al. Role of Nitric Oxide in Hepatopulmonary Syndrome in Cirrhotic Rats Am. J. Respir. Crit. Care Med., September 1, 2001; 164(5): 879 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. L. Jernigan and T. C. Resta Chronic hypoxia attenuates cGMP-dependent pulmonary vasodilation Am J Physiol Lung Cell Mol Physiol, June 1, 2002; 282(6): L1366 - L1375. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
